Literature DB >> 18491069

[Breast cancer imaging].

M Funke1, C Villena.   

Abstract

Advances in female breast imaging have substantially influenced the diagnosis, therapy, and prognosis of breast cancer in the past few years. Mammography using conventional or digital technique is considered the gold standard for the early detection of breast cancer. Other modalities such as breast ultrasound and contrast-enhanced magnetic resonance imaging of the breast play an important role in diagnostic imaging, staging, and follow-up of breast cancer. Percutaneous needle biopsy is a faster, less invasive, and more cost-effective method than surgical biopsy for verifying the histological diagnosis. New methods such as breast tomosynthesis, contrast-enhanced mammography, and positron emission tomography promise to further improve breast imaging. Further studies are mandatory to adapt these new methods to clinical needs and to evaluate their performance in clinical practice.

Entities:  

Mesh:

Year:  2008        PMID: 18491069     DOI: 10.1007/s00117-008-1676-z

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  41 in total

1.  American Cancer Society guidelines for breast cancer screening: update 2003.

Authors:  Robert A Smith; Debbie Saslow; Kimberly Andrews Sawyer; Wylie Burke; Mary E Costanza; W Phil Evans; Roger S Foster; Edward Hendrick; Harmon J Eyre; Steven Sener
Journal:  CA Cancer J Clin       Date:  2003 May-Jun       Impact factor: 508.702

2.  Assessment of breast cancer vascularisation by Doppler ultrasound as a prognostic factor of survival.

Authors:  Dirk Watermann; Helmut Madjar; Willi Sauerbrei; Valerie Hirt; Heinrich Prömpeler; Elmar Stickeler
Journal:  Oncol Rep       Date:  2004-04       Impact factor: 3.906

3.  Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years.

Authors:  P P Rosen; C Kosloff; P H Lieberman; F Adair; D W Braun
Journal:  Am J Surg Pathol       Date:  1978-09       Impact factor: 6.394

4.  The accuracy of "one-stop" diagnosis for 1,110 patients presenting to a symptomatic breast clinic.

Authors:  A Eltahir; J A Jibril; J Squair; S D Heys; A K Ah-See; G Needham; F J Gilbert; H E Deans; M E McKean; L M Smart; O Eremin
Journal:  J R Coll Surg Edinb       Date:  1999-08

5.  MRI of the breast in patients with metastatic disease of unknown primary.

Authors:  C Schorn; U Fischer; S Luftner-Nagel; J P Westerhof; E Grabbe
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

6.  Diagnostic performance of digital versus film mammography for breast-cancer screening.

Authors:  Etta D Pisano; Constantine Gatsonis; Edward Hendrick; Martin Yaffe; Janet K Baum; Suddhasatta Acharyya; Emily F Conant; Laurie L Fajardo; Lawrence Bassett; Carl D'Orsi; Roberta Jong; Murray Rebner
Journal:  N Engl J Med       Date:  2005-09-16       Impact factor: 91.245

7.  MRI of occult breast carcinoma in a high-risk population.

Authors:  Elizabeth A Morris; Laura Liberman; Douglas J Ballon; Mark Robson; Andrea F Abramson; Alexandra Heerdt; D David Dershaw
Journal:  AJR Am J Roentgenol       Date:  2003-09       Impact factor: 3.959

8.  MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer.

Authors:  Constance D Lehman; Constantine Gatsonis; Christiane K Kuhl; R Edward Hendrick; Etta D Pisano; Lucy Hanna; Sue Peacock; Stanley F Smazal; Daniel D Maki; Thomas B Julian; Elizabeth R DePeri; David A Bluemke; Mitchell D Schnall
Journal:  N Engl J Med       Date:  2007-03-28       Impact factor: 91.245

9.  Intraductal carcinoma of the breast: follow-up after biopsy only.

Authors:  D L Page; W D Dupont; L W Rogers; M Landenberger
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

10.  Dose comparison between screen/film and full-field digital mammography.

Authors:  Gisella Gennaro; Cosimo di Maggio
Journal:  Eur Radiol       Date:  2006-05-30       Impact factor: 7.034

View more
  1 in total

1.  [Not every form of breast cancer can be demarcated with MRI].

Authors:  B Walter
Journal:  Radiologe       Date:  2010-10       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.